Friday, April.20.2018
TOP NEWS
|
REGULATORY
|
BUSINESS
|
ORGANIZATION
|
ACADEMIA
Home
>
ORGANIZATION
Astellas Becomes 1st Japan Maker to Join PhRMA Leadership
February 14.2018
Private Univ. Group Encourages “Single-Product, Single-Price” Deals in Response to New Distribution GL, Tougher Medical Fee Cut Rules
February 9.2018
“Unprecedented Reforms to Take Place as a Result of Chuikyo’s Leadership”: JMA Pres. Yokokura
February 8.2018
Japan Could Miss Out on Wave 1 of Drug Development, Re-Do and Do Right on PMP: PhRMA
January 30.2018
Japan Pharma Leader Says Pricing Overhaul Would Not Expand Drug Lag
January 18.2018
Exclude 50 Yen or Lower Price Generics from “Off-Year” Re-Pricing: JGA Chief
January 15.2018
Pharma Leaders Air Bleak Outlook on New PMP Scheme at New Year’s Reception
January 10.2018
JPMA to Call for Improvements in PMP-Eligibility Criteria, Company Requirements: Chief
December 22.2017
Continued Discussions Needed for PMP-Eligible Products, Company Criteria: FPMAJ/JPMA
December 22.2017
PhRMA/EFPIA Rap Japan’s Drug Pricing Reform, Warn of Grave Consequences
December 21.2017
< Prev
1
2
3
4
5
6
7
8
9
10
Next >
With Drug Price Cuts Done, MHLW Now Running Ministry-Wide Initiative to Shave Prescriptions
G1/G2 Rule:
G1/G2ルール
It Is Thumbs Up for Cell Therapy in Japan
Biosimilar Use Essential to Sustain Universal Health Coverage: Society President(Apr.19)
MHLW Sees Solid Inquiry Numbers for Conditional Early Approval System: Official(Apr.19)
Toho Grabs 8% Stake in NKT Cell Immunotherapy Startup(Apr.19)
Astellas Sells Agensys Research Facilities to Kite(Apr.19)
US Appeals Court Favors Sumitomo Dainippon in Latuda Substance Patent Suit(Apr.19)
1.
AZ’s PD-L1 Inhibitor Durvalumab Up for M...
2.
PhRMA Chief Warns of Serious Implication...
3.
Pricing OK’ed for Dupixent, Tecentriq, L...
4.
Chuikyo Payer Rep Questions New Premium ...
5.
MHLW to Issue Optimal Use Guidelines for...
1.
AZ’s PD-L1 Inhibitor Durvalumab Up for M...
2.
Single Generic Pricing Rule Will Acceler...
3.
Opdivo Faces 23.8% Price Cut as Slew of ...
4.
Lilly Japan Sales Up 7% in 2017, Upbeat ...
5.
MHLW Health Policy Chief Questions Volum...